Cargando…
Therapeutic effect of a TM4SF5-specific peptide vaccine against colon cancer in a mouse model
Molecular-targeted therapy has gained attention because of its high efficacy and weak side effects. Previously, we confirmed that transmembrane 4 superfamily member 5 protein (TM4SF5) can serve as a molecular target to prevent or treat hepatocellular carcinoma (HCC). We recently extended the applica...
Autores principales: | Kwon, Sanghoon, Kim, Young-Eun, Park, Jeong-A, Kim, Doo-Sik, Kwon, Hyung-Joo, Lee, Younghee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163885/ https://www.ncbi.nlm.nih.gov/pubmed/24286311 http://dx.doi.org/10.5483/BMBRep.2014.47.4.157 |
Ejemplares similares
-
Therapeutic effect of a TM4SF5-specific monoclonal antibody against colon cancer in a mouse model
por: Kim, Young-Eun, et al.
Publicado: (2014) -
Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells
por: Park, Sangkyu, et al.
Publicado: (2020) -
Prevention and Therapy of Hepatocellular Carcinoma by Vaccination with TM4SF5 Epitope-CpG-DNA-Liposome Complex without Carriers
por: Kwon, Sanghoon, et al.
Publicado: (2012) -
Anti-metastatic effect of the TM4SF5-specific peptide vaccine and humanized monoclonal antibody on colon cancer in a mouse lung metastasis model
por: Wu, Guang, et al.
Publicado: (2016) -
A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model
por: Park, Sangkyu, et al.
Publicado: (2018)